Dr. Pamela A. Lepera, DO
- Medicare services, 2024
- 120
- Medicare patients, 2024
- 106
- Part D claims, 2024
- 84
- Publications
- 2
- Clinical trials
- 4
- Practice address
- 2100 Stantonsburg Rd, Greenville, NC 27834
- Practice phone
- Call (252) 847-4100
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Lepera's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Pamela A. Lepera is a hematologist and oncologist in Greenville, North Carolina
Dr. Lepera practices at ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina.
Dr. Lepera's NPI, 1053304212, was assigned on August 23, 2005. Dr. Lepera graduated from Philadelphia College of Osteopathic Medicine in 1988. Dr. Lepera holds North Carolina license 9600983.
- NPI
- 1053304212NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7012936339
- NPI enumeration date
- August 23, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (252) 847-4100
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 64
- Medical school graduation
- 1988
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Pamela A. Lepera practices at ECU Health Medical Center in Greenville, North Carolina
Dr. Lepera's primary practice is ECU Health Medical Center, at 2100 Stantonsburg Rd, Greenville, NC 27834 in Pitt County. The practice phone is (252) 847-4100.
- ECU Health Medical Center2100 Stantonsburg Rd, Greenville, NC 27834 · Pitt CountyPhone(252) 847-4100
Source: Dmand AI Affiliation Data
Dr. Pamela A. Lepera is affiliated with 5 sites of care and 4 medical groups
Dr. Lepera's primary practice is ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina. The medical group on file is ECU Health. Dmand AI also links Dr. Lepera to 3 more group practices and clinics, 3 medical groups and 1 home health agency, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Pamela A. Lepera's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lepera practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| ECU Health Medical Center | Available with a free account |
| +4 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University Health Systems of Eastern Carolina and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Pamela A. Lepera is one of 420 hematologists and oncologists in North Carolina
Hematology and oncology is Dr. Lepera's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lepera is board certified in medical oncology by the American Board of Internal Medicine. Dr. Lepera is licensed in North Carolina.
Specialties and state licenses
- Hematology and oncology, North CarolinaPrimary
Hematologists and oncologists near Dr. Lepera
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Pamela A. Lepera billed Medicare for 120 services in 2024
CMS data shows 120 Medicare services from Dr. Lepera across 4 procedure codes in 2024, for 106 Medicare patients. Medicare paid $9,962 for them.
Dr. Lepera's Medicare services by type, 2022 to 2024
- 2022
- 2024
- Office and hospital visits
- 2022: 3732024: 12068%
Where Dr. Lepera's Medicare services took place, 2024
- In an office8067%
- In a facility4033%
Dr. Lepera compared with the North Carolina median for hematologists and oncologists, 2024
- Dr. Lepera
- North Carolina median
- Medicare services
- 120vs 45073% below
- Medicare patients
- 106vs 18041% below
- Part D claims
- 25vs 32492% below
Medians across 402 hematologists and oncologists in North Carolina with Dmand AI profiles that report each measure.
Dr. Lepera's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Lepera?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lepera and other hematologists and oncologists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Pamela A. Lepera treated 106 Medicare patients in 2024, average age 75
CMS counts 106 Medicare patients who saw Dr. Lepera in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Lepera's median patient age at 74, with 59% women.
Dr. Lepera's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Lepera's Medicare patients by sex, 2024
- Women5653%
- Men5047%
Chronic conditions among Dr. Lepera's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer53%
- Arthritis52%
- Ischemic heart disease42%
- Diabetes37%
- Anxiety36%
- Chronic kidney disease34%
Share of Medicare patients with each condition. A patient can have several.
Dr. Lepera's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women59%
- Men40%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Pamela A. Lepera wrote 84 Medicare Part D claims in 2024
In 2024, Dr. Lepera wrote 84 Medicare Part D claims for 40 patients. 89% of them were for generic drugs. CMS names the drug for 25 of them, across 1 drug with 11 or more claims each, at $535 in total drug cost. In 2022, CMS named 373 claims across 16 drugs.
Dr. Lepera's Part D claims by kind of drug, 2024
- Generic75 claims89%
- Brand-name and other9 claims11%
Dr. Lepera's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 3732023: 2593%
Drugs named by CMS: 1 in 2023, 16 in 2022.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Pamela A. Lepera scored 97 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Lepera for performance year 2024, reported through an alternative payment model (APM). Dr. Lepera accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lepera as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Lepera's MIPS scores, performance year 2024
- 97of 100Final score
- 82.4of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Pamela A. Lepera has 2 publications on record
Dmand AI links 2 papers to Dr. Lepera, published from 2015 to 2021. Dr. Lepera's most frequent co-authors are Tithi Biswas, MD, Brian N. Brodish, MD and Andrew W. Ju, MD.
Dr. Lepera's most frequent co-authors
Recent publications by Dr. Lepera
See who Dr. Lepera researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lepera works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Pamela A. Lepera has worked on 4 clinical trials
Dmand AI links Dr. Lepera to 4 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Brain Neoplasms, Central Nervous System Neoplasms and Meningioma. Alliance for Clinical Trials in Oncology sponsors the most, 2.
Clinical trials with Dr. Lepera by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Lepera's trials
- Brain Neoplasms
- Central Nervous System Neoplasms
- Meningioma
- Pancreatic Intraductal Neoplasms
- Meningeal Neoplasms
Investigators on the most trials with Dr. Lepera
- Clinton H. Leinweber, DO2 shared trials
- Aaron P. Provenzano2 shared trials
- Hui-Kuo George Shu, MD2 shared trials
Recent clinical trials with Dr. Lepera
Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases (opens in a new tab)
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Pamela A. Lepera received $7,093 in industry payments from 2016 to 2025
CMS Open Payments shows 493 general payments to Dr. Lepera from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Merck Sharp & Dohme Corporation paid the most, $809.
General payments to Dr. Lepera by program year, 2016 to 2025
General payments to Dr. Lepera by kind, 2016 to 2025
- Food and beverage$6,71695%
- Education$3775%
Companies that paid Dr. Lepera the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Pamela A. Lepera graduated from Philadelphia College of Osteopathic Medicine
Dr. Lepera graduated from Philadelphia College of Osteopathic Medicine in 1988.
- Medical school
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Sources for Dr. Pamela A. Lepera's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Pamela A. Lepera
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Pamela A. Lepera's NPI number?
Dr. Pamela A. Lepera's NPI number is 1053304212. It was assigned on August 23, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Pamela A. Lepera?
Dr. Pamela A. Lepera is a hematologist and oncologist in Greenville, North Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Pamela A. Lepera practice?
Dr. Lepera practices at 2100 Stantonsburg Rd, Greenville, NC 27834. Dr. Lepera's primary practice is ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina. Dmand AI also links Dr. Lepera to 3 group practices and clinics, 3 medical groups and 1 home health agency.
What is Dr. Pamela A. Lepera's office phone number?
The practice phone on file for Dr. Lepera is (252) 847-4100.
What is Dr. Pamela A. Lepera's medical license number?
Dr. Lepera holds North Carolina license 9600983.
Which hospitals is Dr. Pamela A. Lepera affiliated with?
Dr. Lepera practices at ECU Health Medical Center in Greenville, North Carolina.
What medical group is Dr. Pamela A. Lepera part of?
Dr. Lepera is linked to ECU Health. Dmand AI links Dr. Lepera to 3 more medical groups.
Does Dr. Pamela A. Lepera accept Medicare?
Yes. CMS data shows Dr. Lepera billed Medicare for 120 services in 2024, and Dr. Lepera accepts Medicare assignment.
Does Dr. Pamela A. Lepera offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Lepera as offering telehealth services.
What is Dr. Pamela A. Lepera's MIPS score?
Dr. Lepera's MIPS final score for performance year 2024 is 97 out of 100, reported through an alternative payment model (APM).
Show 9 more questionsShow fewer questions
How many Medicare patients does Dr. Pamela A. Lepera see?
CMS counts 106 Medicare patients who saw Dr. Lepera in 2024, with an average age of 75.
Is Dr. Pamela A. Lepera board certified?
Yes. Dr. Lepera is board certified in medical oncology by the American Board of Internal Medicine.
What services does Dr. Pamela A. Lepera bill to Medicare?
In 2024, Dr. Lepera's most billed Medicare services were office visit, established patient (99214), hospital inpatient care (99232) and hospital inpatient care (99222).
Where did Dr. Pamela A. Lepera go to medical school?
Dr. Lepera graduated from Philadelphia College of Osteopathic Medicine in 1988.
What drugs does Dr. Pamela A. Lepera prescribe most?
In 2023 Medicare Part D data, Dr. Lepera's most prescribed drugs by claims were Anastrozole.
Has Dr. Pamela A. Lepera received payments from drug or device companies?
CMS Open Payments shows $7,093 in general payments to Dr. Lepera from 56 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Pamela A. Lepera been practicing?
Dr. Lepera graduated from medical school in 1988, 38 years ago.
Does Dr. Pamela A. Lepera do research?
Dmand AI links 2 publications to Dr. Lepera, published from 2015 to 2021. Dr. Lepera has worked on 4 clinical trials.
Who does Dr. Pamela A. Lepera publish with?
Dr. Lepera's most frequent co-authors are Tithi Biswas, MD (1 shared paper), Brian N. Brodish, MD (1 shared paper) and Andrew W. Ju, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card